• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Serum anti-myomeglin antibodies is a useful tumor marker to detect gastrointestinal cancer

Research Project

Project/Area Number 17591370
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Digestive surgery
Research InstitutionChiba University

Principal Investigator

SHIMADA Hideaki  Chiba University, GRADUATE SCHOOL OF MEDICINE, ASSISTANTPROFESSOR, 大学院医学研究院, 講師 (20292691)

Co-Investigator(Kenkyū-buntansha) HIWASA Takaki  Chiba University, GRADUATE SCHOOL OF MEDICINE, ASSOCIATE PROFESSOR, 大学院医学研究院, 助教授 (30260251)
OCHIAI Takenori  Chiba University, GRADUATE SCHOOL OF MEDICINE, 大学院医学研究院, 教授 (80114255)
Project Period (FY) 2005 – 2006
Project Status Completed (Fiscal Year 2006)
Budget Amount *help
¥3,300,000 (Direct Cost: ¥3,300,000)
Fiscal Year 2006: ¥1,600,000 (Direct Cost: ¥1,600,000)
Fiscal Year 2005: ¥1,700,000 (Direct Cost: ¥1,700,000)
KeywordsSEREX / Esophageal cancer / Squamous cell carcinoma / tumor marker / prognosis / myomegalin / 胃癌 / 大腸癌 / 癌抗原 / IgG抗体
Research Abstract

In order to identify new serum markers of esophageal squamous cell carcinoma (SCC), we performed serological identification of antigens by recombinant cDNA expression cloning (SEREX). E. coli was infected with λZAPII phage cDNA library prepared from mRNA of an esophageal cancer cell line (T.Tn), and IPTG-induced cDNA products were screened for interaction with antibodies in allogeneic sera of patients with esophageal SCC. We identified myomegalin (phosphodiesterase 4D interacting protein/PDE4DIP) as a new SEREX antigen for esophageal SCC. Western blotting analysis revealed that serum anti-myomegalin antibodies (s-myomegalin-Abs) were present in 43 out of 91 (47%) patients but in only one out of 45 (2.2%) healthy controls. Anti-myomegalin Abs were present 38% of stage I patients. The positive rate of s-myomegalin-Abs was the highest among the other conventional tumor markers. Although the presence of s-myomegalin-Abs was not related to any of clinicopathological features of the patients concerned, multivariate analysis indicated that presence of s-myomegalin-Abs was significantly associated with favorable prognosis

Report

(3 results)
  • 2006 Annual Research Report   Final Research Report Summary
  • 2005 Annual Research Report
  • Research Products

    (7 results)

All 2007 2006

All Journal Article (7 results)

  • [Journal Article] Serum anti-myomegalin antibodies in patients with esophageal squamous cell carcinoma2007

    • Author(s)
      Shimada, H., Kuboshima, M., Shiratori, T., Nabeya, Y., Takeuchi, A., Takagi, H., Nomura, F., Takiguchi, M., Ochiai, T., Hiwasa, T
    • Journal Title

      International Journal of Oncology 30

      Pages: 97-103

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2006 Annual Research Report 2006 Final Research Report Summary
  • [Journal Article] Serum anti-myomegalin antibodies in patients with esophageal squamous cell carcinoma2007

    • Author(s)
      Shimada, H., Kuboshima, M., Shiratori, T., Nabeya, Y., Takeuchi, A., Takagi, H., Nomura, F., Takiguchi, M., Ochiai, T., Hiwasa, T.
    • Journal Title

      International Journal of Oncology

      Pages: 3097-3103

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] Serological identification of antigens by recombinant cDNA expression cloning (SEREX) using antibodies from patients with esophageal squamous cell carcinoma2006

    • Author(s)
      Hiwasa, T., Shimada, H., Ochiai, T., Takiguchi
    • Journal Title

      Moleculomics and Thereafter

      Pages: 99-117

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] Serological identification of antigens by recombinant cDNA expression cloning (SEREX) using antibodies from patients with esophageal squamous cell carcinoma2006

    • Author(s)
      Hiwasa, T., Shimada, H., Ochiai, T., Takiguchi
    • Journal Title

      Moleculomics and Thereafter 26

      Pages: 99-117

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2006 Annual Research Report 2006 Final Research Report Summary
  • [Journal Article] An essential role of alternative splicing of c-myc suppressor FUSE-binding protein-interacting repressor in carcinogenesis.2006

    • Author(s)
      Matsushita K, Tomonaga T, Shimada H, Shioya A, Higashi M, Matsubara H, Harigaya K, Nomura F, Libutti D, Levens D, Ochiai T.
    • Journal Title

      Cancer Res. 66(3)

      Pages: 1409-1417

    • Related Report
      2005 Annual Research Report
  • [Journal Article] Proteomic analysis of primary esophageal squamous cell carcinoma reveals down regulation of a cell adhesion protein, periplakin.2006

    • Author(s)
      Nishimori T, Tomonaga T, Matsushita K, Oh-Ishi M, Kodera Y, Maeda T, Nomura F, Matsubara H, Shimada H, Ochiai T.
    • Journal Title

      Proteomics 6(3)

      Pages: 1011-1018

    • Related Report
      2005 Annual Research Report
  • [Journal Article] Identification of a novel SEREX antigen, SLC2A1/GLUT1, in esophageal squamous cell carcinoma.2006

    • Author(s)
      Kuboshima M, Shimada H, Liu TL, Nakashima K, Nomura F, Takiguchi M, Hiwasa T, Ochiai T.
    • Journal Title

      Int J Oncol. 28(2)

      Pages: 463-468

    • Related Report
      2005 Annual Research Report

URL: 

Published: 2005-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi